NCT05058391 - A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

April 6, 2024

Study Completion Date

April 18, 2024

Conditions

Hunter Syndrome

Interventions

BIOLOGICAL

Elaprase

Elaprase IV infusion.

Trial Locations (5)

SAT Hospital - Govt Medical College, Thiruvananthapuram

Sir Gangaram Hospital, New Delhi

JK Lone Hospital, Jaipur

Institute of Child Health, Kolkata

All India Institute of Medical Sciences (AIIMS), New Delhi